To access this element change to forms mode OFF

Closed Grant Opportunity View - GO3922

Australia-India Strategic Research Fund Round 13 - COVID-19 Collaborative Research Projects

Contact Details

Phone:
13 28 46

Email Address:

Web Address:

GO ID:
GO3922
Agency:
Department of Industry, Science, Energy and Resources
Close Date & Time:
2-Jul-2020 5:00 pm (ACT Local Time)
Show close time for other time zones
Primary Category:
231021 - Health and Medical Research
Publish Date:
4-Jun-2020
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, Administered Territories
Selection Process:
Open Competitive

Description:

The AISRF provides grants for collaborative research projects with Indian partners. For Round 13 of the AISRF, your project must involve research in a COVID-19 focused priority area and must be mutually beneficial for Australia and India with outcomes that contribute to the global response to the COVID-19 pandemic.

  • the minimum grant amount is $300,000
  • the maximum grant amount is $600,000
  • the maximum project period is up to twelve months

The lead organisation may submit a maximum of 2 applications:

  • one with a corresponding Indian partner application being submitted under the Science and Technology Fund with India's Department of Science and Technology (DST)
  • one with a corresponding Indian partner application being submitted under the Biotechnology Fund with India's Department of Biotechnology (DBT)

Round 13 Priority Areas

Your project must be in a priority area. The priority areas for Round 13 - COVID 19 Collaborative Research Projects are:

Indo-Australian Science & Technology Fund (administered by DST in India)

  • Antiviral coatings, other preventive technologies
  • Data analytics, modelling, Artificial Intelligence applications
  • Screening and diagnostic testing

Indo-Australian Biotechnology Fund (administered by DBT in India)

  • Development of immunotherapeutics
  • Development of animal model/ in vitro model for vaccine development
  • Assay development and validation for testing of vaccines and therapeutics
  • Viral genomics and bioinformatics 
Eligibility:

To be eligible you must:

  • have an Australian Business Number (ABN)

and be one of the following entities:

  • a publicly funded research organisation (PFRO) as defined in section 14 of the grant opportunity guidelines
  • a Cooperative Research Centre (CRC)
  • an Australian State/Territory Government agency or body

Additionally, we can only accept applications that have a primary Indian partner who has submitted, or is in the process of submitting, a corresponding application to India’s DST or DBT.

Joint applications involving more than one Australian partner are acceptable and industry involvement (including businesses) is encouraged where appropriate, provided the lead applicant is the main driver of the project and eligible to apply. For further information on joint applications, refer to section 7.2 of the grant opportunity guidelines.

Total Amount Available (AUD):
$3,000,000.00
Estimated Grant Value (AUD):
From $300,000.00 to $600,000.00
Instructions for Application Submission:
Other Instructions:

business.gov.au provides information and advice to customers via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.

Contact Details

Phone:
13 28 46

Email Address:

Web Address: